tiprankstipranks
Crispr Therapeutics AG (CRSP)
NASDAQ:CRSP
US Market

Crispr Therapeutics AG (CRSP) Income Statement

Compare
9,015 Followers

Crispr Therapeutics AG Income Statement

Last quarter (Q4 2024), Crispr Therapeutics AG's total revenue was $35.00M, a decrease of -82.50% from the same quarter last year. In Q4, Crispr Therapeutics AG's net income was $-37.31M. See Crispr Therapeutics AG’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 35.00M$ 371.21M$ 436.00K$ 913.08M$ 543.00K
Gross Profit
$ 37.31M$ 240.96M$ -109.81M$ 895.13M$ -268.86M
Operating Expenses
$ 503.88M$ 462.29M$ 563.35M$ 539.55M$ 354.98M
Depreciation and Amortization
$ 0.00$ 19.84M$ 24.17M$ 17.95M$ 9.18M
EBITDA
$ -466.57M$ -202.70M$ -648.99M$ 391.48M$ -345.25M
Operating Income
$ -466.57M$ -222.54M$ -673.16M$ 373.53M$ -354.44M
Other Income/Expenses
$ 103.90M$ 71.82M$ 22.66M$ 6.00M$ 6.38M
Pretax Income
$ -362.67M$ -150.72M$ -650.50M$ 379.53M$ -348.06M
Net Income
$ -366.25M$ -153.61M$ -650.17M$ 377.66M$ -348.87M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -4.34$ -1.94$ -8.36$ 4.97$ -5.29
Diluted EPS
$ -4.34$ -1.94$ -8.36$ 4.70$ -5.29
Weighted Average Shares Outstanding
84.36M 79.22M 77.75M 75.95M 65.95M
Weighted Average Shares Outstanding (Diluted)
84.36M 79.22M 77.75M 80.39M 65.95M
Currency in USD

Crispr Therapeutics AG Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis